Venture Map · Round
53Biologics — Other
Announced 2026-03-25 · Valladolid · Biotech / CDMO
Valladolid-based GMP biomanufacturing company 53Biologics raised an undisclosed amount in a round led by European private equity firm Ren Life Sciences, with long-standing investor Inveready participating. The capital funds expansion of GMP capacity, service consolidation and international growth; no stage was disclosed.
RoundOther
LeadRen Life Sciences
Date2026-03-25
CityValladolid
SectorBiotech / CDMO
The company
Investors 2
R
Ren Life Sciences
IInveready
inveready.com